Evaluate the Efficacy and Safety of Rosuvastatin Versus Simvastatin in Type 2 Diabetic Patients With Dyslipidemia

NCT00506961 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

90

Enrollment

OTHER_GOV

Sponsor class

Conditions

Diabetes Mellitus
Dyslipidemia

Interventions

DRUG: Rosuvastatin
DRUG: Simvastatin

Sponsor

Taipei Veterans General Hospital, Taiwan